DONGWHA PHARM.CO.,LTD Logo

DONGWHA PHARM.CO.,LTD

Develops, manufactures, and sells a diverse portfolio of healthcare products globally.

000020 | KO

Overview

Corporate Details

ISIN(s):
KR7000020008
LEI:
Country:
South Korea
Address:
서울특별시 중구 서소문로9길 20, 중구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1897, Dongwha Pharm is a pioneering pharmaceutical company with a long history of serving public health. The company is engaged in the research, development, manufacturing, and sale of a diverse portfolio of healthcare products. Its offerings span multiple categories, including prescription pharmaceuticals (ethical drugs), over-the-counter (OTC) medicines, medical devices, quasi-drugs, cosmetics, and health functional foods and beverages. As a fully integrated company, Dongwha Pharm operates its own R&D centers, manufacturing facilities, and a nationwide sales and marketing network. It is committed to innovation, continuously developing new drugs and launching consumer health brands while also exporting its products to global markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.0 MB
2025-08-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.5 KB
2025-07-31 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.2 KB
2025-07-15 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 13.6 KB
2025-06-30 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 11.2 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 851.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.5 MB
2025-04-30 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.1 KB
2025-04-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-16 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 52.2 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.1 KB
2025-03-26 00:00
Post-Annual General Meeting Information
[기재정정]정기주주총회결과
Korean 31.0 KB
2025-03-26 00:00
Board/Management Information
대표이사(대표집행임원)변경(안내공시)
Korean 6.0 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.3 KB
2025-03-24 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 130.7 KB

Automate Your Workflow. Get a real-time feed of all DONGWHA PHARM.CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONGWHA PHARM.CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONGWHA PHARM.CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BOIRON Logo
Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.
France
BOI
Bon Natural Life Ltd Logo
Bio-manufactures natural plant ingredients for fragrances, supplements, and immunity solutions.
United States of America
BON
Bosnalijek d.d. Sarajevo Logo
Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.
Bosnia and Herzegovina
BSNL
Boundless Bio, Inc. Logo
Developing ecDNA-directed therapies for intractable oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma creating small molecule drugs for RAS-dependent cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and genetically driven cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Developing next-gen serotonergic drugs for neurological and psychiatric disorders like epilepsy.
United States of America
DRUG
BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America
BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea
003000
Burning Rock Biotech Ltd Logo
Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.
United States of America
BNR

Talk to a Data Expert

Have a question? We'll get back to you promptly.